Latest News on EVH

Financial News Based On Company


Advertisement
Advertisement

Evolent Health ( EVH ) Reports Q2 Loss, Misses Revenue Estimates

https://www.zacks.com/stock/news/2680770/evolent-health-evh-reports-q2-loss-misses-revenue-estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -211.11% and -2.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

EVH Earnings Drop 31%

https://www.fool.com/data-news/2025/08/07/evh-earnings-drop-31/
Evolent Health ( NYSE:EVH ) , a company specializing in technology-enabled specialty care management solutions for healthcare providers and payers, reported its Q2 2025 earnings on August 7, 2025. The headline from the company's results was a miss on both GAAP revenue and adjusted earnings per ...

iRhythm Technologies ( IRTC ) Reports Q2 Loss, Tops Revenue Estimates

https://www.zacks.com/stock/news/2645822/irhythm-technologies-irtc-reports-q2-loss-tops-revenue-estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of +39.62% and +7.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Evolent Health ( EVH ) Q2 Earnings Expected to Decline

https://www.zacks.com/stock/news/2643916/earnings-preview-evolent-health-evh-q2-earnings-expected-to-decline
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health ( EVH ) Stock Jumps 6.9%: Will It Continue to Soar?

https://www.zacks.com/stock/news/2534901/evolent-health-evh-stock-jumps-69-will-it-continue-to-soar
Evolent Health (EVH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Advertisement

Evolent Health ( EVH ) Q1 Earnings Lag Estimates

https://www.zacks.com/stock/news/2465676/evolent-health-evh-q1-earnings-lag-estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -33.33% and 4.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Analysts Believe Evolent Health ( EVH ) Could Rally 53.33%: Here's is How to Trade

https://www.zacks.com/stock/news/2464117/wall-street-analysts-believe-evolent-health-evh-could-rally-5333-heres-is-how-to-trade
The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Medicare Advantage Rates Expected To Climb Over 5%: CMS - Alignment Healthcare ( NASDAQ:ALHC )

https://www.benzinga.com/government/regulations/25/04/44694563/medicare-advantage-rates-expected-to-climb-over-5-in-2026-easing-pressure-on-managed-care
2026 Medicare Advantage payments to rise by 5.06%, up from the prior 2.23% estimate. CMS revised the effective growth rate to 9.04%, from an earlier 5.93%. Feel unsure about the market's next move? Copy trade alerts from Matt Maley-a Wall Street veteran who consistently finds profits in volatile ...

Evolent Health ( EVH ) Reports Q4 Loss, Lags Revenue Estimates

https://www.zacks.com/stock/news/2419109/evolent-health-evh-reports-q4-loss-lags-revenue-estimates
Evolent Health (EVH) delivered earnings and revenue surprises of 0% and 1.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health ( EVH ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

https://www.zacks.com/stock/news/2416784/evolent-health-evh-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures
Beyond analysts' top -and-bottom-line estimates for Evolent Health (EVH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Advertisement

Earnings Preview: Evolent Health ( EVH ) Q4 Earnings Expected to Decline

https://www.zacks.com/stock/news/2415529/earnings-preview-evolent-health-evh-q4-earnings-expected-to-decline
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

New Strong Sell Stocks for January 30th

https://www.zacks.com/stock/news/2406245/new-strong-sell-stocks-for-january-30th
DEC, ERO and EVH have been added to the Zacks Rank #5 (Strong Sell) List on January 30, 2024.

Dr. Abeer AbouYabis Scholarship for Future Doctors Inspires Aspiring Physicians to Tackle Healthcare Challenges

https://www.benzinga.com/pressreleases/25/01/g42936943/dr-abeer-abouyabis-scholarship-for-future-doctors-inspires-aspiring-physicians-to-tackle-healthcar
SMYRNA, Ga., Jan. 12, 2025 ( GLOBE NEWSWIRE ) -- The prestigious Dr. Abeer AbouYabis Scholarship for Future Doctors is now accepting applications from undergraduate students nationwide who are driven to pursue a career in medicine.

New Strong Sell Stocks for December 26th

https://www.zacks.com/stock/news/2388023/new-strong-sell-stocks-for-december-26th
ATI, BATRA and EVH have been added to the Zacks Rank #5 (Strong Sell) List on December 26, 2024.

New Strong Sell Stocks for December 12th

https://www.zacks.com/stock/news/2382495/new-strong-sell-stocks-for-december-12th
ASH, BIDU and EVH have been added to the Zacks Rank #5 (Strong Sell) List on December 12, 2024.
Advertisement

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul - A.O. Smith ( NYSE:AOS ) , Anglo American ( OTC:AAUKF )

https://www.benzinga.com/ma/24/11/42025534/deal-dispatch-shell-unilever-and-more-are-on-the-sell-side-the-onion-makes-alex-jones-cry-foul
Evolent Health Inc EVH is reportedly up for sale. The Arlington, Virginia-based software provide initiated an auction process after receiving takeover inquiries. Among the potential suitors are TPG Inc TPG, Clayton, Dubilier & Rice, and KKR & Co. Inc.

S&P 500 Tops 6,000; Sezzle Shares Spike Higher - Sezzle ( NASDAQ:SEZL )

https://www.benzinga.com/news/earnings/24/11/41855544/s-sezzle-shares-spike-higher
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.6% on Friday. The Dow traded up 0.83% to 44,092.10 while the NASDAQ rose 0.20% to 19,308.79. The S&P 500 also rose, gaining, 0.60% to 6,009.11. Consumer staples shares surged by 1.8% on Friday.

Dow Tops 44,000; US Consumer Sentiment Increases In November - Nature's Miracle Holding ( NASDAQ:NMHI )

https://www.benzinga.com/news/earnings/24/11/41852319/dow-tops-44000-us-consumer-sentiment-increases-in-november
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining more than 250 points on Friday. The Dow traded up 0.62% to 44,001.69 while the NASDAQ fell 0.01% to 19,268.55. The S&P 500 also rose, gaining, 0.40% to 5,997.19. Utilities shares surged by 1.6% on Friday.

US Stocks Mixed; Fluor Earnings Miss Views - Tivic Health Systems ( NASDAQ:TIVC )

https://www.benzinga.com/24/11/41845926/us-stocks-mixed-fluor-earnings-miss-views
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.2% on Friday. Following the market opening Friday, the Dow traded up 0.20% to 43,817.98 while the NASDAQ fell 0.10% to 19,250.88. The S&P 500 also rose, gaining, 0.13% to 5,981.13. Utilities shares surged by 1% on ...

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Pinterest ( NYSE:PINS )

https://www.benzinga.com/trading-ideas/movers/24/11/41843551/sweetgreen-posts-downbeat-results-joins-evolent-health-redfin-pinterest-and-other-big-stocks
U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.2% on Friday. Shares of Sweetgreen, Inc. SG fell sharply in today's pre-market trading after the company reported worse-than-expected quarterly financial results.
Advertisement

Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Upstart Hldgs ( NASDAQ:UPST )

https://www.benzinga.com/24/11/41838655/why-upstart-shares-are-trading-higher-by-over-23-here-are-20-stocks-moving-premarket
Shares of Upstart Holdings, Inc. UPST rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results. Upstart reported quarterly losses of seven cents per share which beat the analyst consensus estimate for losses of 15 cents.

Evolent Health ( EVH ) Q3 Earnings and Revenues Lag Estimates

https://www.zacks.com/stock/news/2366901/evolent-health-evh-q3-earnings-and-revenues-lag-estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -86.67% and 0.67%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Unlocking Q3 Potential of Evolent Health ( EVH ) : Exploring Wall Street Estimates for Key Metrics

https://www.zacks.com/stock/news/2365099/unlocking-q3-potential-of-evolent-health-evh-exploring-wall-street-estimates-for-key-metrics
Beyond analysts' top -and-bottom-line estimates for Evolent Health (EVH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.

Why Evolent Health ( EVH ) is Poised to Beat Earnings Estimates Again

https://www.zacks.com/stock/news/2364649/why-evolent-health-evh-is-poised-to-beat-earnings-estimates-again
Evolent Health (EVH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

KANZHUN LIMITED Sponsored ADR ( BZ ) to Report Q3 Results: What Awaits?

https://www.zacks.com/stock/news/2364473/kanzhun-limited-sponsored-adr-bz-to-report-q3-results-what-awaits
Kanzhun (BZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Advertisement

Evolent Health ( EVH ) Reports Next Week: What to Know Ahead of the Release

https://www.zacks.com/stock/news/2361890/evolent-health-evh-reports-next-week-what-to-know-ahead-of-the-release
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Is Elevance Health Stock Trading Lower On Thursday? - Evolent Health ( NYSE:EVH )

https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41388721/why-is-elevance-health-stock-trading-lower-on-thursday
Elevance Health Inc. ELV reported on Thursday third-quarter revenues of $44.7 billion, up 5.3% year-over-year, beating the consensus of $43.33 billion. The increase was driven by higher premium yields in the Health Benefits segment and growth in CarelonRx product revenue, partially offset by ...

Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms - Evolent Health ( NYSE:EVH )

https://www.benzinga.com/m-a/24/08/40529349/evolent-health-explores-sale-garners-inbound-interest-from-private-equity-firms
Evolent Health Inc EVH is reportedly up for sale. What Happened: The Arlington, Virginia-based software provide initiated an auction process after receiving takeover inquiries from private equity firms and healthcare providers.

Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday - Expedia Group ( NASDAQ:EXPE )

https://www.benzinga.com/news/24/08/40290461/expedia-posts-upbeat-earnings-joins-akamai-technologies-trade-desk-dxc-technology-and-other-big-stoc
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday. Shares of Expedia Group, Inc. EXPE rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results.

Evolent Health ( EVH ) Surpasses Q2 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2319538/evolent-health-evh-surpasses-q2-earnings-and-revenue-estimates
Evolent Health (EVH) delivered earnings and revenue surprises of 42.86% and 2.04%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Evolent Health ( EVH ) Moves 12.8% Higher: Will This Strength Last?

https://www.zacks.com/stock/news/2303208/evolent-health-evh-moves-128-higher-will-this-strength-last
Evolent Health (EVH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify

https://www.prnewswire.com/news-releases/evolent-signs-agreement-to-acquire-artificial-intelligence-utilization-management-products-and-team-from-machinify-302162679.html
• Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automation • Machinify technology leverages the latest advances in applied machine learning, large language models and ...

Evolent Health ( EVH ) Q1 Earnings and Revenues Top Estimates

https://www.zacks.com/stock/news/2271857/evolent-health-evh-q1-earnings-and-revenues-top-estimates
Evolent Health (EVH) delivered earnings and revenue surprises of 61.90% and 6.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Evolent Announces First Quarter 2024 Results

https://www.prnewswire.com/news-releases/evolent-announces-first-quarter-2024-results-302141715.html
WASHINGTON, May 9, 2024 /PRNewswire/ -- Evolent Health, Inc. ( NYSE: EVH ) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended ...

Define Ventures Welcomes Frank Williams as Venture Partner

https://www.prnewswire.com/news-releases/define-ventures-welcomes-frank-williams-as-venture-partner-302111128.html
The Evolent Health co-founder and former CEO and chairman joins Define on the heels of raising $460 million across two funds SAN FRANCISCO, April 9, 2024 /PRNewswire/ -- , the largest firm focused on early-stage digital health companies, today announced veteran healthcare leader Frank Williams ...
Advertisement

Stocks Flashing Renewed Technical Strength: Veeva Systems Cl A

https://www.investors.com/ibd-data-stories/stocks-flashing-renewed-technical-strength-veeva-systems-cl-a/
Veeva Systems Cl A ( VEEV ) had its Relative Strength ( RS ) Rating upgraded from 79 to 83 Wednesday. X This exclusive rating from Investor's Business Daily tracks share price action with a 1 ( worst ) to 99 ( best ) score.

Does Evolent Health ( EVH ) Have the Potential to Rally 34.46% as Wall Street Analysts Expect?

https://www.zacks.com/stock/news/2240714/does-evolent-health-evh-have-the-potential-to-rally-3446-as-wall-street-analysts-expect
The average of price targets set by Wall Street analysts indicates a potential upside of 34.5% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Evolent Health Cl A Meets 80-Plus Relative Strength Rating Benchmark

https://www.investors.com/ibd-data-stories/evolent-health-cl-a-meets-80-plus-relative-strength-rating-benchmark/
Evolent Health Cl A ( EVH ) had its Relative Strength ( RS ) Rating upgraded from 78 to 81 Monday. X IBD's proprietary RS Rating tracks technical performance by using a 1 ( worst ) to 99 ( best ) score that shows how a stock's price action over the last 52 weeks matches up against that of all ...

IBD Rating Upgrades: Certara Shows Improved Relative Price Strength

https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-certara-shows-improved-relative-price-strength/
Certara ( CERT ) had its Relative Strength ( RS ) Rating upgraded from 70 to 73 Friday - a welcome improvement, but still shy of the 80 or better score you look for. X This exclusive rating from Investor's Business Daily tracks share price action with a 1 ( worst ) to 99 ( best ) score.

Evolent Health Cl A Shows Rising Price Performance With Jump To 82 RS Rating

https://www.investors.com/ibd-data-stories/evolent-health-cl-a-shows-rising-price-performance-with-jump-to-82-rs-rating/
Evolent Health Cl A ( EVH ) had its Relative Strength ( RS ) Rating upgraded from 77 to 82 Wednesday. X IBD's proprietary rating measures market leadership with a 1 ( worst ) to 99 ( best ) score. The score shows how a stock's price behavior over the trailing 52 weeks stacks up against all ...
Advertisement

Phreesia Shows Rising Relative Price Performance; Still Shy Of Key Benchmark

https://www.investors.com/ibd-data-stories/phreesia-shows-rising-relative-price-performance-still-shy-of-key-benchmark/
Phreesia Shows Rising Relative Price Performance. Still Shy Of Key Benchmark Investor's Business Daily ...

Wall Street Analysts Predict a 35.7% Upside in Evolent Health ( EVH ) : Here's What You Should Know

https://www.zacks.com/stock/news/2232505/wall-street-analysts-predict-a-357-upside-in-evolent-health-evh-heres-what-you-should-know
The consensus price target hints at a 35.7% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Stocks Showing Improving Market Leadership: Hims & Hers Health Earns 84 RS Rating

https://www.investors.com/ibd-data-stories/stocks-showing-improving-market-leadership-hims-hers-health-earns-84-rs-rating/
Hims & Hers Health ( HIMS ) had its Relative Strength ( RS ) Rating upgraded from 75 to 84 Tuesday. X When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength. IBD's unique rating identifies market leadership with a 1 ( worst ) to 99 ( ...

Phreesia Shows Improved Relative Strength; Still Shy Of Benchmark

https://www.investors.com/ibd-data-stories/phreesia-shows-improved-relative-strength-still-shy-of-benchmark/
Phreesia Shows Improved Relative Strength. Still Shy Of Benchmark Investor's Business Daily ...

HIMS Stock Breaks Out On Powerful Turnaround Quarter

https://www.investors.com/news/stocks-showing-improving-market-leadership-hims-hers-health-earns-84-rs-rating/
HIMS Stock Breaks Out On Turnaround Quarter Investor's Business Daily ...
Advertisement

These Analysts Revise Their Forecasts On Evolent Health After Upbeat Results - Evolent Health ( NYSE:EVH )

https://www.benzinga.com/news/earnings/24/02/37291944/these-analysts-revise-their-forecasts-on-evolent-health-after-upbeat-results
Evolent Health, Inc. EVH reported better-than-expected fourth-quarter results on Thursday. Evolent Health posted quarterly earnings of 23 cents per share, beating market estimates of 15 cents per share.

Evolent Health ( EVH ) Q4 2023 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2024/02/23/evolent-health-evh-q4-2023-earnings-call-transcrip/
EVH earnings call for the period ending December 31, 2023.

Evolent Announces Fourth Quarter and Full Year 2023 Results

https://www.prnewswire.com/news-releases/evolent-announces-fourth-quarter-and-full-year-2023-results-302069232.html
WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. ( NYSE: EVH ) , a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three ...

Blackbird Health Nests A Fresh $17 Million To Become The Gold Standard In Precision Mental Healthcare

https://www.forbes.com/sites/sethjoseph/2024/02/21/blackbird-health-nests-a-fresh-17-million-to-become-the-gold-standard-in-precision-mental-healthcare/
While calling attention to the importance of mental health in America isn't new, the pandemic and past four years have brought the issues into focus.

New Strong Buy Stocks for January 5th

https://www.zacks.com/commentary/2205453/new-strong-buy-stocks-for-january-5th
ORGO, CALM, W, NET and EVH have been added to the Zacks Rank #1 (Strong Buy) List on January 5, 2024.
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion